Department of Animal Science, Michigan State University, East Lansing 48824.
Michigan State Extension, East Lansing 48824.
J Dairy Sci. 2020 Dec;103(12):12104-12108. doi: 10.3168/jds.2020-18361. Epub 2020 Sep 25.
Transition milk (TM, defined here as the second through fourth milkings after calving) supplies additional fat, protein, and immunoglobulins to the calf compared with milk replacer at industry-suggested feeding rates (∼14% solids). Our objective was to determine whether 9 feedings of TM on d 2 through 4 of life increase the growth rate and overall health of calves. Holstein heifer calves on a commercial farm were randomly assigned to 1 of 3 diets (n = 35/diet): milk replacer (MR; Purina Warm Front BOV MOS Medicated Milk Replacer, St. Louis, MO), TM, or a 50:50 blend of MR and colostrum replacer (MCR; Alta HiCal Colostrum Powder Replacer, the Saskatoon Colostrum Company Ltd., Saskatoon, SK, Canada). The TM was harvested from Holstein cows on the farm, pooled, and pasteurized at 71.7°C for 15 s. Nutrient composition on a dry matter basis of TM was 25.9% fat, 41.8% protein, and 14% solids; MR was 10.3% fat, 27.8% protein, and 14% solids; and MCR was 14.6% fat, 38.6% protein, and 15% solids. All calves received IgG-enriched colostrum replacer for the first 2 feedings after birth. Subsequently, calves were fed 1.9 L of MR, TM, or MCR 3 times per day for 3 d (starting on d 2). After initial diets ended, calves were fed and managed similarly. Body weights (d 1, 7, 14, 21, and 56), blood samples (d 1, 7, 14, and 21), and daily health scores (scale of 0 to 3, with 0 representing normal or healthy and 3 representing severe symptoms or ill) were collected through weaning at 56 d. All except 1 calf achieved successful transfer of passive immunity, with serum IgG values greater than 10.0 mg/mL. From birth through weaning, calves fed TM and MCR gained 3 kg more total body weight than those fed MR (34.3, 34.3, and 31.3 kg, respectively). Increased metabolizable energy (using NRC 2001 recommendations) in TM accounts for 0.68 kg of the increased gain compared with MR. Treatment did not alter health scores for ears, eyes, or feces. Haptoglobin concentrations were lower in TM and MCR than in MR calves (4.63, 3.62, and 7.54 µg/mL, respectively), whereas lipopolysaccharide binding protein concentrations were not different. In conclusion, compared with MR alone, feeding TM or MR with colostrum replacer for 3 d increased growth rate of calves throughout the preweaning period.
过渡乳(TM,这里定义为产后第 2 至第 4 次挤奶)与代乳料相比,为犊牛提供了额外的脂肪、蛋白质和免疫球蛋白,在行业建议的喂养率下(约 14%固体物)。我们的目的是确定在生命的第 2 至第 4 天,每天喂食 9 次 TM 是否会提高犊牛的生长速度和整体健康水平。在一家商业农场,荷斯坦小母牛被随机分配到 3 种饮食之一(n = 35/饮食):代乳料(MR;普瑞纳 Warm Front BOV MOS 药用代乳料,圣路易斯,密苏里州)、TM 或代乳料和初乳代乳料(MCR; Alta HiCal 初乳粉代乳料,萨斯喀彻温省初乳公司,萨斯卡通,SK,加拿大)的 50:50 混合物。TM 是从农场的荷斯坦奶牛中采集的,经过混合,在 71.7°C 下巴氏消毒 15 秒。TM 的干物质基础的营养成分是 25.9%脂肪、41.8%蛋白质和 14%固体物;MR 是 10.3%脂肪、27.8%蛋白质和 14%固体物;MCR 是 14.6%脂肪、38.6%蛋白质和 15%固体物。所有的小牛在出生后的头 2 次喂食中都接受了富含 IgG 的初乳代乳料。随后,小牛每天喂食 3 次,每次 1.9 升 MR、TM 或 MCR,持续 3 天(从第 2 天开始)。初始饮食结束后,小牛以类似的方式喂养和管理。体重(第 1、7、14、21 和 56 天)、血液样本(第 1、7、14 和 21 天)和每日健康评分(0 到 3 分,0 表示正常或健康,3 表示严重症状或患病)在 56 天大断奶时收集。除了 1 头小牛外,所有小牛都成功地实现了被动免疫转移,血清 IgG 值大于 10.0 毫克/毫升。从出生到断奶,与喂食 MR 的小牛相比,喂食 TM 和 MCR 的小牛的总体重增加了 3 公斤(分别为 34.3、34.3 和 31.3 公斤)。与 MR 相比,TM 中的可代谢能量(使用 NRC 2001 推荐值)增加了 0.68 公斤,这解释了体重增加的部分原因。处理方式并没有改变耳朵、眼睛或粪便的健康评分。与喂食 MR 的小牛相比,TM 和 MCR 组的触珠蛋白浓度较低(分别为 4.63、3.62 和 7.54µg/mL),而脂多糖结合蛋白浓度没有差异。总之,与单独喂食 MR 相比,在断奶前的整个阶段,每天喂食 3 天 TM 或与初乳代乳料混合的 TM 可提高犊牛的生长速度。